Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen

Name: Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen
License: Public Domain

Centre Hospitalier Universitaire de Saint Etienne

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

healthy volunteers

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 150369
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.